Autopsy report · NCT04141423

Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Part 1 completed. Part 2 not initiated”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 6 months before it stopped.
55 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Biocon Limited
Sponsor type: Industry
Conditions: Type 1 Diabetes Mellitus (T1DM)
Interventions: Tregopil
Participants: 55
Sites: 1
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.